Published in J Biol Chem on November 05, 1987
Cloning and expression of the gene for the cross-reactive alpha antigen of Mycobacterium kansasii. Infect Immun (1990) 2.06
Chemical basis of rough and smooth variation in mycobacteria. J Bacteriol (1989) 1.68
Structure of a new glycolipid from the Mycobacterium avium-Mycobacterium intracellulare complex. J Bacteriol (1999) 0.88
Building a better bacillus: the emergence of Mycobacterium tuberculosis. Front Microbiol (2014) 0.85
Activation of human neutrophils by mycobacterial phenolic glycolipids. Clin Exp Immunol (1999) 0.81
Functional characterisation of three o-methyltransferases involved in the biosynthesis of phenolglycolipids in Mycobacterium tuberculosis. PLoS One (2013) 0.78
Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science (1994) 3.90
Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol (2001) 2.20
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis (2001) 1.72
Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guérin and ability to induce granuloma and recruit natural killer T cells. J Biol Chem (2001) 1.70
Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J Immunol (1995) 1.70
Structure of a human gammadelta T-cell antigen receptor. Nature (2001) 1.65
Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. J Immunol (1997) 1.63
Vgamma9/Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur J Immunol (2000) 1.57
Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry. J Biol Chem (1993) 1.36
Deglycosylation of the 45/47-kilodalton antigen complex of Mycobacterium tuberculosis decreases its capacity to elicit in vivo or in vitro cellular immune responses. Infect Immun (1999) 1.32
CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. J Immunol (1997) 1.30
The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol (2007) 1.29
The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guérin. Heterogeneity, structure, and role in the regulation of cytokine secretion. J Biol Chem (1997) 1.21
Mycobacterium tuberculosis H37Rv parietal and cellular lipoarabinomannans. Characterization of the acyl- and glyco-forms. J Biol Chem (2000) 1.20
3-Formyl-1-butyl pyrophosphate A novel mycobacterial metabolite-activating human gammadelta T cells. J Biol Chem (1999) 1.20
Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern. J Biol Chem (1999) 1.19
Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis. Front Biosci (1998) 1.16
Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells. J Biol Chem (2001) 1.14
Mannosylated lipoarabinomannan antagonizes Mycobacterium tuberculosis-induced macrophage apoptosis by altering Ca+2-dependent cell signaling. J Infect Dis (2000) 1.12
Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect Immun (1998) 1.12
Structural elucidation by field desorption and electron-impact mass spectrometry of the C-mycosides isolated from Mycobacterium smegmatis. Biochim Biophys Acta (1983) 1.11
Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans. Structure and localization of alkali-labile and alkali-stable phosphoinositides. J Biol Chem (1997) 1.11
A nondegradative route for the removal of endotoxin from exopolysaccharides. Anal Biochem (1995) 1.09
Lipoarabinomannans: characterization of the multiacylated forms of the phosphatidyl-myo-inositol anchor by NMR spectroscopy. Biochem J (1999) 1.07
Differential activation of human gammadelta cells by nonpeptide phosphoantigens. Eur J Immunol (2001) 1.05
Newly found 2-N-acetyl-2,6-dideoxy-beta-glucopyranose containing methyl glucose polysaccharides in M.bovis BCG: revised structure of the mycobacterial methyl glucose lipopolysaccharides. Glycobiology (1998) 1.04
The antituberculous Mycobacterium bovis BCG vaccine is an attenuated mycobacterial producer of phosphorylated nonpeptidic antigens for human gamma delta T cells. Infect Immun (1995) 1.04
[Mechanism of glutaraldehyde-protein bond formation]. Biochimie (1976) 1.02
Mannosylated lipoarabinomannan interacts with phagocytes. Eur J Biochem (1995) 1.01
Structural elucidation of the major phenolic glycolipid from Mycobacterium kansasii. I. Evidence for tetrasaccharide structure of the oligosaccharide moiety. J Biol Chem (1987) 1.00
Lipoglycans are putative ligands for the human pulmonary surfactant protein A attachment to mycobacteria. Critical role of the lipids for lectin-carbohydrate recognition. J Biol Chem (2000) 1.00
Comparative structural study of the mannosylated-lipoarabinomannans from Mycobacterium bovis BCG vaccine strains: characterization and localization of succinates. Glycobiology (1997) 0.99
Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors. Eur J Immunol (1997) 0.99
Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy. Leukemia (2010) 0.96
Structural study of the lipomannans from Mycobacterium bovis BCG: characterisation of multiacylated forms of the phosphatidyl-myo-inositol anchor. J Mol Biol (1999) 0.95
Human gamma delta T cells in tuberculosis. Res Immunol (1997) 0.93
Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis. Leukemia (2011) 0.92
A chemical basis for selective recognition of nonpeptide antigens by human delta T cells. FASEB J (2000) 0.92
Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma. Mol Med (2001) 0.92
Specificity of a Mycobacterium kansasii phenolic glycolipid (mycoside A) immunoserum. J Clin Microbiol (1987) 0.91
Structural elucidation of the major phenolic glycolipid from Mycobacterium kansasii. II. Presence of a novel dideoxyhexose. J Biol Chem (1987) 0.90
A novel nucleotide-containing antigen for human blood gamma delta T lymphocytes. Eur J Immunol (1996) 0.89
Characterization and sugar-binding properties of arcelin-1, an insecticidal lectin-like protein isolated from kidney bean (Phaseolus vulgaris L. cv. RAZ-2) seeds. Biochem J (1998) 0.88
Surfactant protein D inhibits mite-induced alveolar macrophage and dendritic cell activations through TLR signalling and DC-SIGN expression. Clin Exp Allergy (2010) 0.88
Absolute configuration of the unique 2,6-dideoxy-4-O-methyl-arabino-hexopyranose of the major phenolic glycolipid antigen from Mycobacterium kansasii. Eur J Biochem (1987) 0.85
Structural analysis of the mannan region of lipoarabinomannan from Mycobacterium bovis BCG. Heterogeneity in phosphorylation state. J Biol Chem (1995) 0.85
Structural definition of arabinomannans from Mycobacterium bovis BCG. Glycoconj J (1999) 0.84
Gammadelta T cell activation or anergy during infections: the role of nonpeptidic TCR ligands and HLA class I molecules. J Leukoc Biol (1997) 0.84
Lipo-oligosaccharidic antigen from Mycobacterium gastri. Complete structure of a novel C4-branched 3,6-dideoxy-alpha-xylo-hexopyranose. Biochemistry (1994) 0.82
Lipooligosaccharidic antigen containing a novel C4-branched 3,6-dideoxy-alpha-hexopyranose typifies Mycobacterium gastri. J Biol Chem (1993) 0.82
Lipoarabinomannans activate the protein tyrosine kinase Hck in human neutrophils. Infect Immun (2000) 0.81
Structural elucidation of novel methylglucose-containing polysaccharides from Mycobacterium xenopi. Eur J Biochem (1995) 0.81
Structural and immunological properties of the phenolic glycolipids from Mycobacterium gastri and Mycobacterium kansasii. Eur J Biochem (1990) 0.80
Lipooligosaccharidic antigens from Mycobacterium kansasii and Mycobacterium gastri. Glycoconj J (1995) 0.79
A flavonoid sulfate antigen activates human alphabeta CD8+ Th2 lymphocytes in pollen allergy. Eur J Immunol (2000) 0.79
Isolation, structural studies and chemical synthesis of a 'palmitone lipid' from Corynebacterium diphtheriae. Chem Phys Lipids (1978) 0.79
Carbohydrate epitope structural elucidation by 1H-NMR spectroscopy of a new Mycobacterium kansasii phenolic glycolipid antigen. Eur J Biochem (1990) 0.79
Mass spectrometry of acylated sugars as trimethylsilyl ether derivatives. A way for location of long chain fatty acyl groups. Biomed Mass Spectrom (1978) 0.79
Characterization of mannooligosaccharide caps in mycobacterial lipoarabinomannan by capillary electrophoresis/electrospray mass spectrometry. Glycobiology (1999) 0.78
Y2K+1 state-of-the-art on non-peptide phosphoantigens, a novel category of immunostimulatory molecules. Microbes Infect (2001) 0.78
Direct evidence of methylglucose lipopolysaccharides/palmitoyl-CoA noncovalent complexes by capillary zone electrophoresis-electrospray/mass spectrometry. Anal Chem (1998) 0.78
A new type of serine-containing glycopeptidolipid from Mycobacterium xenopi. J Biol Chem (1991) 0.78
Structure of a novel glycopeptidolipid antigen containing a O-methylated serine isolated from Mycobacterium xenopi. Complete 1H-NMR and 13C-NMR assignment. Eur J Biochem (1993) 0.77
Activation and control of self-reactive gammadelta T cells. Microbes Infect (1999) 0.77
Characterization of phosphoantigens by high-performance anion-exchange chromatography-electrospray ionization ion trap mass spectrometry and nanoelectrospray ionization ion trap mass spectrometry. Anal Chem (2001) 0.77
New-found phenolic glycolipids in Mycobacterium bovis BCG. Presence of a diglycosylated glycolipid. J Biol Chem (1989) 0.77
A unique phenylalanine-containing lipopeptide isolated from a rough-colony variant of Mycobacterium avium. Eur J Biochem (1996) 0.76
High-pH anion-exchange chromatographic analysis of phosphorylated compounds: application to isolation and characterization of nonpeptide mycobacterial antigens. Anal Biochem (1996) 0.76
Conventional and non-conventional recognition of non-peptide antigens by T lymphocytes. C R Acad Sci III (1999) 0.75
Identification of modified nucleosides in intact transfer ribonucleic acid by pyrolysis-electron impact-collisional activation mass spectrometry. Nucleic Acids Res (1981) 0.75
The serine-threonine kinase p90RSK is a new target of enzastaurin in follicular lymphoma cells. Br J Pharmacol (2013) 0.75
Incorporation of oxygen-18 into nucleosides and bases. Nucleic Acids Res (1977) 0.75
Particular matrix for fast atom bombardment mass spectrometric analysis of phenolic glycolipid antigens isolated from pathogen mycobacteria. Biomed Environ Mass Spectrom (1988) 0.75
Use of 1H NMR ROESY for structural determination of O-glycosylated amino acids from a serine-containing glycopeptidolipid antigen. Biochemistry (1992) 0.75
Occurrence of 3-oxo-acyl groups in the 6,6'-diesters of alpha-D-trehalose. New glycolipids related to cord factor from Corynebacterium diphtheriae. Eur J Biochem (1979) 0.75
Mass spectrometry of oligosaccharides by chloride-attachment reactions: the origin of fragment loss. Carbohydr Res (1985) 0.75
Structural determination of 'cord factor' from a Corynebacterium diphtheriae strain by a combination of mass spectral ionization methods: field desorption cesium cationization and electron impact mass spectrometry studies. Biomed Mass Spectrom (1978) 0.75
Identification of partially methylated methyl glycosides by gas chromatography-mass spectrometry of trimethylsilyl derivatives. Application to mycobacterial glycolipid antigen analysis. J Chromatogr (1988) 0.75
[The role of human dendritic cells in tuberculosis: protector or non-protector?]. Rev Mal Respir (2006) 0.75
Glycerated hemoglobin alpha 2 beta 2(82) (EF6) N-epsilon-glyceryllysine: a new post-translational modification occurring in erythrocyte bisphosphoglyceromutase deficiency. Biomed Biochim Acta (1987) 0.75
Glycerated hemoglobin, alpha 2A beta 2(82) (EF6) N epsilon-glyceryllysine. A new post-translational modification occurring in erythrocyte bisphosphoglyceromutase deficiency. J Biol Chem (1986) 0.75
Comparative studies of the strains PA and PN of Mycobacterium phlei leading to their reclassification: examination of lipids and DNA, biochemical tests and phage typing. Ann Microbiol (Paris) (1980) 0.75
Specific binding of phenolic glycolipid antigens from Mycobacterium bovis BCG with antibodies. FEBS Lett (1992) 0.75
Complete NMR structural elucidation of the capsular polysaccharide adjuvant from Klebsiella I-714. Eur J Biochem (1996) 0.75
Acquisition of a stimulatory activity for Vgamma9/Vdelta2 T cells by a Burkitt's lymphoma cell line without loss of HLA class I expression. Hum Immunol (1999) 0.75
Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gammadelta T lymphocytes and natural killer cells. AIDS (2000) 0.75